yahoo_financeOriginal article
Can-Fite Achieves Key Pivotal Phase 3 Psoriasis Milestone with Completion of Patient Enrolment for the Interim Analysis: Data Expected Q4 2026/Q1 2027
Phase 3Positive
AI Analysis
Summary
Can-Fite completed patient enrollment for the interim analysis of a pivotal Phase 3 psoriasis study, with data expected in Q4 2026 or Q1 2027.
Clinical Trial Data
Phase
Phase 3
Outcome Details
Patient enrolment completed for interim analysis
Importance:6/10
Sentiment:
0.70
Phase 3PsoriasisClinical TrialPatient EnrollmentInterim Analysis
Related Companies
Read the original article
Published by yahoo_finance on July 6, 2026 11:00 AM